Tweets by IDWeek 2023

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Presentation Icons

Live Streamed

On Demand

Back

265 Views

046. COVID-19: Special Populations: Thursday, 12:15 - 1:30 p.m.

Poster Session: COVID-19: Special Populations

(471) In-Depth Characterization of SARS-CoV-2 Variants Causing Breakthrough COVID-19 Among Hospitalized Immunocompromised (IC) Patients with or without Prior Exposure to Tixagevimab-Cilgavimab (T/C) Pre-Exposure Prophylaxis (PrEP)

Thursday, October 12, 2023

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Presenting Author(s)

GH

Ghady Haidar, MD (he/him/his)

Assistant Professor of Medicine
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States

Co-Author(s)

JJ

Jana L. Jacobs, PhD

Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
ES

Erin Salese, BS

Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
JL

Justin Ludwig, MA

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
AH

Amy Heaps, MS

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
UP

Urvi Parikh, PhD

University of Pittsburgh
Pittsburgh, Pennsylvania, United States
RS

Rahil Sethi, MS

Department of Biomedical Informatics, University of Pittsburgh, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
LC

Lori Caruso, BS

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
HC

Haley Camacho, PharmD candidate

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
TC

Tina Chinakarn, MPH

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
SE

Stacey Edick, MPAS, PA-C

Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
DF

Dawn Fischer, RN

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
Kailey Hughes Kramer, PhD, MPH (she/her/hers)

Assistant Professor
Division of Infectious Diseases, Department of Medicine, University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States
AL

Amy Lukanski, DNP, RN, CPHQ, CPN

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
KM

Kiersten Marks, BS, BSN

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
NS

Naomi Saenz-Morales, BS

University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
SS

Sara Sierra, MD

Office of Quality and Clinical Research Innovation, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
Pittsburgh, Pennsylvania, United States
CF

Cátia Ferreira, PhD

Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA
Wilmington, Delaware, United States
LG

Lisa Glasser, MD

Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA
Wilmington, Delaware, United States
KH

Kathleen Heil, RN, BSN

Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Wilmington, DE, USA
Wilmington, Delaware, United States
CT

Carla Talarico, PhD, MPH

Vaccines and Immune Therapies, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA
Gaithersburg, Maryland, United States
ST

Sylvia Taylor, PhD, MPH, MBA

Medical Evidence, Vaccines and Immune Therapies Unit, AstraZeneca, Cambridge, UK
Cambridge, England, United Kingdom
Erin K. McCreary, PharmD (she/her/hers)

Director of Infectious Diseases Improvement and Clinical Research Innovation
University of Pittsburgh Medical Center
Pittsburgh, PA, United States
JM

John W. Mellors, MD

Chief
University of Pittsburgh School of Medicine
Pittsburgh, Pennsylvania, United States